https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Ventilation inhomogeneities in children with congenital thoracic malformations https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28065 Tue 24 Aug 2021 14:27:26 AEST ]]> Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54560 Thu 29 Feb 2024 10:27:50 AEDT ]]> Altered sputum granzyme B and granzyme B/proteinase inhibitor-9 in patients with non-eosinophilic asthma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21345 n = 10), and patients with NEA (n = 22) or eosinophilic asthma (EA) (n = 15) using flow cytometry. Results: Granzyme B expression and the ratio of granzyme B to PI-9 positive cells were highest in those with NEA for both CD3+ and CD4+ T cells. The expression of granzyme B was not statistically different between patients with NEA and EA; however, the ratio of granzyme B to PI-9 positive cells for CD3+ T cells was significantly higher in those with NEA compared with EA. Conclusions: Induced sputum provides a non-invasive tool for investigating T cell cytotoxic mediators in the various asthma subtypes. Granzyme B expression is increased in NEA and the contribution of granzyme B to chronic inflammation requires further study.]]> Sat 24 Mar 2018 07:51:24 AEDT ]]> Pathophysiology of severe asthma: We've only just started https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47496 Mon 23 Jan 2023 11:54:34 AEDT ]]>